Advertisement
Screener

Exelixis Inc (EXEL) Basic Shares Outstanding (Weighted Average)

2.8 / 5 stars · 68/120 Roast Me

Exelixis Inc Basic Shares Outstanding (Weighted Average)

Exelixis Inc (EXEL) reported Basic Shares Outstanding (Weighted Average) of 250.81 million shares for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-05.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05

  • Exelixis Inc weighted average number of shares outstanding, basic for the quarter ending 2026-07-03 was 250.81M shares, a 7.99% decline year-over-year.
  • Exelixis Inc weighted average number of shares outstanding, basic for the quarter ending 2026-04-03 was 258.33M shares, a 7.34% decline year-over-year.
  • Exelixis Inc weighted average number of shares outstanding, basic for the quarter ending 2026-01-02 was 266.46M shares, a 6.35% decline year-over-year.
  • Exelixis Inc weighted average number of shares outstanding, basic for the quarter ending 2025-10-03 was 268.42M shares, a 6.02% decline year-over-year.
  • Exelixis Inc weighted average number of shares outstanding, basic for fiscal 2026 was 271.57M shares, a 6.37% decline from fiscal 2025.
  • Exelixis Inc weighted average number of shares outstanding, basic for fiscal 2025 was 290.03M shares, a 8.84% decline from fiscal 2023.
  • Exelixis Inc weighted average number of shares outstanding, basic for fiscal 2023 was 318.15M shares, a 1.05% decline from fiscal 2022.
  • Exelixis Inc weighted average number of shares outstanding, basic for fiscal 2022 was 321.53M shares, a 2.11% increase from fiscal 2021.
Period endWeighted Average Number of Shares Outstanding, Basic 3 monthWeighted Average Number of Shares Outstanding, Basic 3 month as first filedWeighted Average Number of Shares Outstanding, Basic 6 monthWeighted Average Number of Shares Outstanding, Basic 9 monthWeighted Average Number of Shares Outstanding, Basic 9 month as first filedWeighted Average Number of Shares Outstanding, Basic 12 month
2026-07-03250.81M shares
10-Q · filed 2026-08-05
254.57M shares
10-Q · filed 2026-08-05
258.53M shares
derived: average of 3 quarters · filed 2026-08-05
261.00M shares
derived: average of 4 quarters · filed 2026-08-05
2026-04-03258.33M shares
10-Q · filed 2026-05-05
262.39M shares
derived: average of 2 quarters · filed 2026-05-05
264.40M shares
derived: average of 3 quarters · filed 2026-05-05
266.45M shares
derived: average of 4 quarters · filed 2026-08-05
2026-01-02266.46M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
267.44M shares
derived: average of 2 quarters · filed 2026-02-10
269.15M shares
derived: average of 3 quarters · filed 2026-08-05
271.57M shares
10-K · filed 2026-02-10
2025-10-03268.42M shares
10-Q · filed 2025-11-04
270.50M shares
derived: average of 2 quarters · filed 2026-08-05
273.27M shares
10-Q · filed 2025-11-04
276.08M shares
derived: average of 4 quarters · filed 2026-08-05
2025-07-04272.58M shares
10-Q · filed 2026-08-05
275.69M shares
10-Q · filed 2026-08-05
278.64M shares
derived: average of 3 quarters · filed 2026-08-05
280.38M shares
derived: average of 4 quarters · filed 2026-08-05
2025-04-04278.80M shares
10-Q · filed 2026-05-05
281.66M shares
derived: average of 2 quarters · filed 2026-05-05
282.98M shares
derived: average of 3 quarters · filed 2026-05-05
284.54M shares
derived: average of 4 quarters · filed 2026-05-05
2025-01-03284.52M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
285.07M shares
derived: average of 2 quarters · filed 2026-02-10
286.45M shares
derived: average of 3 quarters · filed 2026-02-10
290.03M shares
10-K · filed 2026-02-10
2024-09-27285.62M shares
10-Q · filed 2025-11-04
287.42M shares
derived: average of 2 quarters · filed 2025-11-04
291.87M shares
10-Q · filed 2025-11-04
296.02M shares
derived: average of 4 quarters · filed 2026-02-10
2024-06-28289.22M shares
10-Q · filed 2025-07-28
294.99M shares
10-Q · filed 2025-07-28
299.49M shares
derived: average of 3 quarters · filed 2026-02-10
303.49M shares
derived: average of 4 quarters · filed 2026-02-10
2024-03-29300.76M shares
10-Q · filed 2025-05-13
304.62M shares
derived: average of 2 quarters · filed 2026-02-10
308.25M shares
derived: average of 3 quarters · filed 2026-02-10
312.24M shares
derived: average of 4 quarters · filed 2026-02-10
2023-12-29308.49M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
311.99M shares
derived: average of 2 quarters · filed 2026-02-10
316.06M shares
derived: average of 3 quarters · filed 2026-02-10
318.15M shares
10-K · filed 2026-02-10
2023-09-29315.50M shares
10-Q · filed 2024-10-29
319.85M shares
derived: average of 2 quarters · filed 2024-10-29
321.37M shares
10-Q · filed 2024-10-29
321.84M shares
derived: average of 4 quarters · filed 2025-02-11
2023-06-30324.20M shares
10-Q · filed 2024-08-06
324.31M shares
10-Q · filed 2024-08-06
323.96M shares
derived: average of 3 quarters · filed 2025-02-11
323.51M shares
derived: average of 4 quarters · filed 2025-02-11
2023-03-31324.42M shares
10-Q · filed 2024-04-30
323.84M shares
derived: average of 2 quarters · filed 2025-02-11
323.27M shares
derived: average of 3 quarters · filed 2025-02-11
322.74M shares
derived: average of 4 quarters · filed 2025-02-11
2022-12-30323.26M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11
322.70M shares
derived: average of 2 quarters · filed 2025-02-11
322.17M shares
derived: average of 3 quarters · filed 2025-02-11
321.53M shares
10-K · filed 2025-02-11
2022-09-30322.15M shares
10-Q · filed 2023-11-01
321.63M shares
derived: average of 2 quarters · filed 2023-11-01
320.95M shares
10-Q · filed 2023-11-01
320.10M shares
derived: average of 4 quarters · filed 2024-02-06
2022-07-01321.12M shares
10-Q · filed 2023-08-01
320.35M shares
10-Q · filed 2023-08-01
319.42M shares
derived: average of 3 quarters · filed 2024-02-06
318.41M shares
derived: average of 4 quarters · filed 2024-02-06
2022-04-01319.58M shares
10-Q · filed 2023-05-09
318.57M shares
derived: average of 2 quarters · filed 2024-02-06
317.51M shares
derived: average of 3 quarters · filed 2024-02-06
316.66M shares
derived: average of 4 quarters · filed 2024-02-06
2021-12-31317.57M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-06
316.47M shares
derived: average of 2 quarters · filed 2024-02-06
315.69M shares
derived: average of 3 quarters · filed 2024-02-06
314.88M shares
10-K · filed 2024-02-06
2021-10-01315.38M shares
10-Q · filed 2022-11-01
314.75M shares
derived: average of 2 quarters · filed 2022-11-01
313.99M shares
10-Q · filed 2022-11-01
313.19M shares
derived: average of 4 quarters · filed 2023-02-07
2021-07-02314.12M shares
10-Q · filed 2022-08-09
313.30M shares
10-Q · filed 2022-08-09
312.45M shares
derived: average of 3 quarters · filed 2023-02-07
311.62M shares
derived: average of 4 quarters · filed 2023-02-07
2021-04-02312.47M shares
10-Q · filed 2022-05-10
311.62M shares
derived: average of 2 quarters · filed 2023-02-07
310.79M shares
derived: average of 3 quarters · filed 2023-02-07
310.04M shares
derived: average of 4 quarters · filed 2023-02-07
2021-01-01310.77M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07
309.94M shares
derived: average of 2 quarters · filed 2023-02-07
309.23M shares
derived: average of 3 quarters · filed 2023-02-07
308.27M shares
10-K · filed 2023-02-07
2020-10-02309.12M shares
10-Q · filed 2021-11-02
308.46M shares
derived: average of 2 quarters · filed 2021-11-02
307.44M shares
10-Q · filed 2021-11-02
306.66M shares
derived: average of 4 quarters · filed 2022-02-18
2020-07-03307.81M shares
10-Q · filed 2021-08-05
306.60M shares
10-Q · filed 2021-08-05
305.84M shares
derived: average of 3 quarters · filed 2022-02-18
305.20M shares
derived: average of 4 quarters · filed 2022-02-18
2020-04-03305.39M shares
10-Q · filed 2021-05-06
304.86M shares
derived: average of 2 quarters · filed 2022-02-18
304.33M shares
derived: average of 3 quarters · filed 2022-02-18
303.80M shares
derived: average of 4 quarters · filed 2022-02-18
2020-01-03304.34M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18
303.80M shares
derived: average of 2 quarters · filed 2022-02-18
303.26M shares
derived: average of 3 quarters · filed 2022-02-18
302.58M shares
10-K · filed 2022-02-18
2019-09-27303.27M shares
10-Q · filed 2020-11-05
302.73M shares
derived: average of 2 quarters · filed 2020-11-05
302.00M shares
10-Q · filed 2020-11-05
301.12M shares
derived: average of 4 quarters · filed 2020-11-05
2019-06-28302.19M shares
10-Q · filed 2020-08-06
301.37M shares
10-Q · filed 2020-08-06
300.40M shares
derived: average of 3 quarters · filed 2020-08-06
299.90M shares
derived: average of 4 quarters · filed 2020-08-06
2019-03-29300.54M shares
10-Q · filed 2020-05-05
299.50M shares
derived: average of 2 quarters · filed 2020-05-05
299.14M shares
derived: average of 3 quarters · filed 2020-05-05
298.69M shares
derived: average of 4 quarters · filed 2020-05-05
2018-12-28298.47M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
298.44M shares
derived: average of 2 quarters · filed 2020-02-25
298.07M shares
derived: average of 3 quarters · filed 2020-02-25
297.89M shares
10-K · filed 2021-02-11
2018-09-28298.42M shares
10-Q · filed 2019-10-30
297.88M shares
derived: average of 2 quarters · filed 2019-10-30
297.70M shares
10-Q · filed 2019-10-30
297.05M shares
derived: average of 4 quarters · filed 2020-02-25
2018-06-29297.34M shares
10-Q · filed 2019-07-31
296.87M shares
10-Q · filed 2019-07-31
296.59M shares
derived: average of 3 quarters · filed 2020-02-25
296.01M shares
derived: average of 4 quarters · filed 2020-02-25
2018-03-30296.42M shares
10-Q · filed 2019-05-01
296.22M shares
derived: average of 2 quarters · filed 2020-02-25
295.57M shares
derived: average of 3 quarters · filed 2020-02-25
2017-12-29296.02M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
295.15M shares
derived: average of 2 quarters · filed 2020-02-25
293.59M shares
10-K · filed 2020-02-25
2017-09-30294.27M shares
10-Q · filed 2017-11-01
292.78M shares
10-Q · filed 2017-11-01
2017-09-29294.27M shares
10-Q · filed 2018-11-01
293.73M shares
derived: average of 2 quarters · filed 2018-11-01
292.78M shares
10-Q · filed 2018-11-01
2017-06-30293.19M shares
10-Q · filed 2018-08-01
292.03M shares
10-Q · filed 2017-08-02
2017-03-31290.87M shares
10-Q · filed 2017-05-01
2016-12-30250.53M shares
10-K · filed 2019-02-22
2016-09-30256.32M shares
10-Q · filed 2017-11-01
242.81M shares
derived: average of 2 quarters · filed 2017-11-01
238.02M shares
10-Q · filed 2017-11-01
2016-06-30229.31M shares
10-Q · filed 2017-08-02
228.86M shares
10-Q · filed 2017-08-02
2016-03-31228.30M shares
10-Q · filed 2017-05-01
2016-01-01209.23M shares
10-K · filed 2018-02-26
2013-12-31184.06M shares
10-K · filed 2014-02-20
2012-12-31183.60M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20
174.98M shares
derived: average of 2 quarters · filed 2014-02-20
160.14M shares
10-K · filed 2014-02-20
2012-09-30166.35M shares
10-Q · filed 2012-11-07
152.32M shares
10-Q · filed 2012-11-07
2011-12-31133.79M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20
131.47M shares
derived: average of 2 quarters · filed 2014-02-20
126.02M shares
10-K · filed 2014-02-20
2011-09-30129.15M shares
10-Q · filed 2012-11-07
129.15K shares
10-Q · filed 2011-10-27
123.43M shares
10-Q · filed 2012-11-07
123.43K shares
10-Q · filed 2011-10-27
2010-12-31433.76M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21
216.94M shares
derived: average of 2 quarters · filed 2013-02-21
108.52M shares
10-K · filed 2013-02-21
2010-09-30108.67K shares
10-Q · filed 2011-10-27
108.37K shares
10-Q · filed 2011-10-27
2009-12-31107.07M shares
10-K · filed 2012-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78